Cutaneous neuropathy in Parkinson's disease: a window into brain pathology.
The deposition of alpha-synuclein in the brain, the neuropathological hallmark of Parkinson's disease (PD), follows a distinct anatomical and temporal sequence. This study aimed to characterize alpha-synuclein deposition in cutaneous nerves from patients with PD. We further strived to explore whether peripheral nerve involvement is intrinsic to PD and reflective of known features of brain pathology, which could render it a useful tool for pathogenetic studies and pre-mortem histological diagnosis of PD. We obtained skin biopsies from the distal and proximal leg, back and finger of 31 PD patients and 35 controls and quantified the colocalization of phosphorylated alpha-synuclein in somatosensory and autonomic nerve fibers and the pattern of loss of different subtypes of dermal fibers. Deposits of phosphorylated alpha-synuclein were identified in 16/31 PD patients but in 0/35 controls (p < 0.0001). Quantification of nerve fibers revealed two types of peripheral neurodegeneration in PD: (1) a length-dependent reduction of intraepidermal small nerve fibers (p < 0.05) and (2) a severe non-length-dependent reduction of substance P-immunoreactive intraepidermal nerve fibers (p < 0.0001). The latter coincided with a more pronounced proximal manifestation of alpha-synuclein pathology in the skin. The histological changes did not correlate with markers of levodopa toxicity such as vitamin B12 deficiency. Our findings suggest that loss of peripheral nerve fibers is an intrinsic feature of PD and that peripheral nerve changes may reflect the two types of central alpha-synuclein-related PD pathology, namely neuronal death and axonal degeneration. Detection of phosphorylated alpha-synuclein in dermal nerve fibers might be a useful diagnostic test for PD with high specificity but low sensitivity.
Department of Neurology, University of Würzburg, Josef-Schneider-Str. 11, 97080, Würzburg, Germany, Doppler_K@ukw.de.
Kathrin
K
Doppler
Sönke
S
Ebert
Nurcan
N
Uçeyler
Claudia
C
Trenkwalder
Jens
J
Ebentheuer
Jens
J
Volkmann
Claudia
C
Sommer
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D017776:Autonomic Pathways / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D001415:Back / Q000294:innervation / Q000473:pathology; D001921:Brain / Q000473:pathology*; D005260:Female; D005385:Fingers / Q000294:innervation / Q000473:pathology; D006801:Humans; D007866:Leg / Q000294:innervation / Q000473:pathology; D008297:Male; D008875:Middle Aged; D009410:Nerve Degeneration / Q000378:metabolism / Q000473:pathology / Q000503:physiopathology; D009431:Neural Conduction; D010300:Parkinson Disease / Q000188:drug therapy / Q000473:pathology* / Q000503:physiopathology; D010523:Peripheral Nervous System Diseases / Q000378:metabolism / Q000473:pathology* / Q000503:physiopathology; D010766:Phosphorylation; D012867:Skin / Q000294:innervation* / Q000378:metabolism / Q000473:pathology*; D013373:Substance P / Q000378:metabolism; D014815:Vitamins / Q000097:blood; D051844:alpha-Synuclein / Q000378:metabolism
C497604:SNCA protein, human; D014815:Vitamins; D051844:alpha-Synuclein; D013373:Substance P